Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Marisa Rose Nucci, M.D.

Co-Author

This page shows the publications co-authored by Marisa Nucci and Michelle Hirsch.
Connection Strength

1.355
  1. PNL2: A Useful Adjunct Biomarker to HMB45 in the Diagnosis of Uterine Perivascular Epithelioid Cell Tumor (PEComa). Int J Gynecol Pathol. 2020 Nov; 39(6):529-536.
    View in: PubMed
    Score: 0.234
  2. GATA3 Is a Sensitive and Specific Marker of Benign and Malignant Mesonephric Lesions in the Lower Female Genital Tract. Am J Surg Pathol. 2015 Oct; 39(10):1411-9.
    View in: PubMed
    Score: 0.164
  3. Perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: clinicopathologic and immunohistochemical characterization of 16 cases. Am J Surg Pathol. 2014 Feb; 38(2):176-88.
    View in: PubMed
    Score: 0.147
  4. Stathmin-1 expression as a complement to p16 helps identify high-grade cervical intraepithelial neoplasia with increased specificity. Am J Surg Pathol. 2013 Jan; 37(1):89-97.
    View in: PubMed
    Score: 0.136
  5. Embryonic stem cell transcription factors and D2-40 (podoplanin) as diagnostic immunohistochemical markers in ovarian germ cell tumors. Int J Gynecol Pathol. 2009 Jul; 28(4):347-55.
    View in: PubMed
    Score: 0.107
  6. Coexisting intraepithelial serous carcinomas of the endometrium and fallopian tube: frequency and potential significance. Int J Gynecol Pathol. 2009 Jul; 28(4):308-15.
    View in: PubMed
    Score: 0.107
  7. The role of CD10 staining in distinguishing invasive endometrial adenocarcinoma from adenocarcinoma involving adenomyosis. Mod Pathol. 2003 Jan; 16(1):22-7.
    View in: PubMed
    Score: 0.068
  8. Interobserver reproducibility of the diagnosis of differentiated exophytic vulvar intraepithelial lesion (DEVIL) and the distinction from its mimics. Histopathology. 2021 Jul 02.
    View in: PubMed
    Score: 0.061
  9. Assessment of a Chemotherapy Response Score (CRS) System for Tubo-Ovarian High-Grade Serous Carcinoma (HGSC). Int J Gynecol Pathol. 2019 May; 38(3):230-240.
    View in: PubMed
    Score: 0.053
  10. Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital Tract. Am J Surg Pathol. 2018 02; 42(2):227-233.
    View in: PubMed
    Score: 0.048
  11. Targeted genomic profiling reveals recurrent KRAS mutations and gain of chromosome 1q in mesonephric carcinomas of the female genital tract. Mod Pathol. 2015 Nov; 28(11):1504-14.
    View in: PubMed
    Score: 0.041
  12. Differential expression of p-ERM, a marker of cell polarity, in benign and neoplastic oviductal epithelium. Int J Gynecol Pathol. 2013 Jul; 32(4):345-52.
    View in: PubMed
    Score: 0.035
  13. Serous tubal intraepithelial carcinoma: diagnostic reproducibility and its implications. Int J Gynecol Pathol. 2010 Jul; 29(4):310-4.
    View in: PubMed
    Score: 0.029
  14. High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression. Mod Pathol. 2010 Oct; 23(10):1316-24.
    View in: PubMed
    Score: 0.028
  15. Intercepting early pelvic serous carcinoma by routine pathological examination of the fimbria. Mod Pathol. 2009 Aug; 22(8):985-8.
    View in: PubMed
    Score: 0.026
  16. Histologic and immunohistochemical decision-making in endometrial adenocarcinoma. Mod Pathol. 2008 Aug; 21(8):937-42.
    View in: PubMed
    Score: 0.025
  17. Atypical genital nevi. A clinicopathologic analysis of 56 cases. Am J Surg Pathol. 2008 Jan; 32(1):51-7.
    View in: PubMed
    Score: 0.024
  18. Ewing family of tumours involving the vulva and vagina: report of a series of four cases. J Clin Pathol. 2007 Jun; 60(6):674-80.
    View in: PubMed
    Score: 0.023
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.